Abstract:Background: Asthma is defined by the Global Initiative for Asthma (GINA) as a heterogeneous disease characterized by chronic airway inflammation. The pathogenesis of the disease is better understood with the comprehension of immunological pathways. These pathways differ by the type of recruited cells and released interleukin (IL). Thus, asthma can be classified into subtypes based on the underlying immune mechanism: eosinophilic asthma (EA) and non-eosinophilic asthma (NEA). Patients with EA tend to respond better to inhaled corticosteroid as compared to those with NEA. The distinction of EA is very important in the light of emergent type 2 inflammation targeted therapies. Methods: We performed a 1-year (2018) retrospective cohort analysis of the Nationwide Inpatient Database (NIS). We included all adult patients presenting with severe asthma. Patients were stratified into two groups: eosinophilic severe asthma and non-eosinophilic severe asthma. The primary outcomes measures were the prevalence of chronic steroid use, status asthmaticus, family history of asthma, food, drug and environmental allergies, presence of nasal polyps, allergic rhinitis, allergic dermatitis, need for mechanical ventilation, need for oxygen supplementation, gastroesophageal reflux disease, in-hospital mortality, and length of stay. We performed descriptive statistics. Continuous parametric variables were reported using a mean and standard deviation. Continuous nonparametric variables were reported using a median and interquartile range. To compare the characteristics of the two groups, we used the independent t-test for continuous parametric variables and the Mann-Whitney U test for continuous nonparametric variables. The Chi-square test was used to assess differences in categorical variables. Results: A total of 2,646 patients were included, out of which 882 belonged to the eosinophilic group and 1,764 were in the non-eosinophilic group. Comparing EA versus NEA, we have found that eosinophilic group was characterized by higher percentage of steroid use (18.3% vs. 9.5%, P < 0.001). This group also had higher rates of status asthmaticus and positive family history (P = 0.009 and 0.004, respectively). The presence of allergies, allergic rhinitis, nasal polyps, and allergic dermatitis was higher among patients with eosinophilia. The need for mechanical ventilation and supplemental oxygen was also higher among this group (P < 0.001 for both); however, there was no significant difference in mortality rate (P = 0.347) and the length of hospital stay was similar in both groups (P < 0.001). Conclusion: We showed herein that the eosinophilic subtype of asthma differs widely from the non-eosinophilic phenotype. Clinically, patients with eosinophilia might exhibit different symptomatology, more atopy, and concomitant comorbidities. However, this group might have better response to steroid therapy and might benefit from the new emergent T2 immune targeted therapy. The identification of EA is crucial for better disease control.

Blood eosinophil cationic protein and eosinophil-derived neurotoxin are associated with different asthma expression and evolution in adults

Determination of the Serum ECP Level and Its Clinical Application in Asthma

Eosinophil-derived neurotoxin levels in adults

Urinary eosinophil‐derived neurotoxin is associated with reduced lung function in pediatric asthma

Eosinophil-derived neurotoxin levels in early childhood and association with preschool asthma - A prospective observational study

Correlation of Serum Eosinophil Cationic Protein with the Severity of Allergic Rhinitis in Childhood

Regulation and directed inhibition of ECP production by human neutrophils

The Determinants of Eosinophilia in Patients With Severe Asthma

Levels of serum ECP,T-IgE and PBEC in asthmatic children and their significance

Innate lymphoid cell population distributions and related gene expression characteristics in blood from allergic and nonallergic patients with eosinophilic asthma

Associations between blood eosinophils and decline in lung function among adults with and without asthma

Eosinophil granule proteins in the assessment of airway inflammation in pediatric bronchial asthma

Clinical features and three-year prognosis of AECOPD patients with different levels of blood eosinophils

Association between protein intake, serum albumin and blood eosinophil in US asthmatic adults

[Eotaxin in induced sputum in patients with asthma and chronic bronchitis: relationship with airway inflammation]

Eosinophil Extracellular Traps Drive Asthma Progression Through Neuro-Immune Signals

An Unexpected Cause For Adult-Onset Asthma, Anosmia, And Acute Heart Failure

Noninvasive biomarkers identify eosinophilic esophagitis: A prospective longitudinal study in children

Clinical factors associated with baseline blood eosinophils among patients with asthma or COPD: NOVELTY study

Association Between Cytokeratin 19-Specific IgG and Neutrophil Activation in Asthma

Clinical profile of patients with adult-onset eosinophilic asthma